Kangmei Pharmaceutical Co Ltd (600518.SS) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE0000017M1
Kangmei Pharmaceutical Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 5.19 bn CNY | 5.25 bn CNY |
| Gross profit | 653.37 m CNY | 1.05 bn CNY |
| Operating income | -24.79 m CNY | 111.68 m CNY |
| EBIT | -413.53 m CNY | 61.78 m CNY |
| Net income | 8.57 m CNY | 10.33 m CNY |
| Diluted EPS – continuing operations | 0.00 CNY | 0.00 CNY |
Full history since 1997, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Kangmei Pharmaceutical Co Ltd
Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China. The company offers Chinese patent medicines, chemical medicines, and health food products. It also engages in the operation of Chinese medicinal materials markets; production and sale of medical devices; and operation of pharmaceutical logistics system. The company provides its products through medical institution resources, smart pharmacies, OTC retail, chain drug stores, direct sales, medical e-commerce, mobile medical care, etc. Kangmei Pharmaceutical Co., Ltd. was incorporated in 1997 and is based in Shenzhen, China.
More stocks
- KeyMed Biosciences Inc (2162.HK)
- Lien Hwa Industrial Corp (1229.TW)
- GRAPHIC PACKAGING HOLDING CO (GPK)
- Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773.SZ)
- NOVAGOLD RESOURCES INC (NG)
- Exxaro Resources Ltd (EXX.JO)
- Fujian Newland Computer Co Ltd (000997.SZ)
- KEPCO Engineering & Construction (052690.KS)
- Hebei Changshan Biochem Pharma (300255.SZ)
- Vaisala Oyj (VAIAS.HE)
- Melexis NV (MELE.BR)
- Fibocom Wireless Inc (300638.SZ)
Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.